Deubiquitinating enzyme CYLD negatively regulates RANK signaling and osteoclastogenesis in mice.
Ontology highlight
ABSTRACT: Osteoclastogenesis is a tightly regulated biological process, and deregulation can lead to severe bone disorders such as osteoporosis. The regulation of osteoclastic signaling is incompletely understood, but ubiquitination of TNF receptor-associated factor 6 (TRAF6) has recently been shown to be important in mediating this process. We therefore investigated the role of the recently identified deubiquitinating enzyme CYLD in osteoclastogenesis and found that mice with a genetic deficiency of CYLD had aberrant osteoclast differentiation and developed severe osteoporosis. Cultured osteoclast precursors derived from CYLD-deficient mice were hyperresponsive to RANKL-induced differentiation and produced more and larger osteoclasts than did controls upon stimulation. We assessed the expression pa
SUBMITTER: Jin W
PROVIDER: S-EPMC2276399 | biostudies-literature | 2008 May
REPOSITORIES: biostudies-literature
ACCESS DATA